Defunct Company
Total Trials
2
As Lead Sponsor
As Collaborator
0
Total Enrollment
104
NCT06718478
First in Human Study of SakuraBead for Genicular Artery Embolization to Treat Pain Secondary to Knee Osteoarthritis
Phase: N/A
Role: Lead Sponsor
Start: Dec 5, 2023
Completion: Aug 23, 2024
NCT06550024
SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization
Start: Nov 28, 2024
Completion: Apr 30, 2027